Denali Therapeutics stock rockets into record territory after Biogen investment and...

cafead

Administrator
Staff member
  • cafead   Aug 06, 2020 at 10:52: AM
via Shares of Denali Therapeutics Inc. DNLI, 36.53% rocketed 29% into record territory in premarket trading Thursday, after Biogen Inc. BIIB, 0.06% announced a $465 million equity investment as part of a collaboration on Denali's treatment for Parkinson's disease.

article source
 

<